Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-60
SponsorHaEmek Medical Center, Israel

About this trial

One of every four births in the Western world is induced, usually due to the risk of maternal and fetal morbidity. There are several methods of labor induction, pharmacological and mechanical. In cases of unfavorable cervix (Bishop score is below 5), cervical ripening can be induced by either prostaglandins E2 (slow release 10 mg dinoprostone insert (propess) or vaginal gel 1-2 mg) or mechanically by Foley catheter balloon (FCB).

The efficacy of labor induction of propess versus vaginal gel combined with FCB was not studied previously.

The goal of this randomized controlled trial is to compare the efficacy of propess versus PGE2 vaginal gel combined with FCB in women with singletons undergoing labor induction at term. The main question it aims to answer is to compare the time from the beginning of labor induction until delivery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women at term (37 weeks of gestation or more) with singleton

pregnancies that are intended for IOL.

Initial bishop score <5

No contraindications to receive either treatment.

Disqualifiers

Women with a known hypersensitivity or contraindications to Propess / PGE2.

Parity 5 or more

Labor contractions more than 4 in 20 min

Glaucoma

Trial design

Design model

Parallel

Treatments tested in this trial

  • Dinoprostone vaginal insert

    Drug

    Described in the arm descriptions

  • Dinoprostone gel and Foley catheter balloon

    Combination product

    Described in the arm descriptions

Treatment groups

140 Participants
are divided into 2 treatment groups
Group A: Propess pessaryExperimental treatment 1 intervention
Group B: Sequential PGE2 vaginal gel and Foley catheter balloonExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

comparing the duration of induction-to-vaginal delivery

measuring the duration of Induction-of-labor by Propess versus the combined use of PGE2 gel and balloon catheter by induction-to-vaginal delivery interval from the beginning of the induction according to the chosen patient protocol and until vaginal delivery.

Time frame
from enrollment until final outcome - a month

Secondary outcomes

1

rate of vaginal delivery in 24 and 48 hours from IOL

the number of participants who had vaginal delivery in 24 and 48 hours from the beginning of the induction-of-labor for both protocols

Time frame
from enrollment until final outcome - a month
2

Number of Participants with Treatment-Related Adverse Events

Maternal -gathering the numbers of participants who had adverse events such as chorioamnionitis, endometritis, postpartum hemorrhage, uterine rupture, Neonatal -gathering the numbers of participants who had adverse events such as uterine hypertonia (contractions exceeding more than two minutes in duration) and/or tachysystole (more than 5 contractions in 10 minutes, averaged over a 30-minute period) with and without decelerations, non-reassuring fetal heart rate according to fetal monitoring, meconium-stained amniotic liquor, umbilical artery pH less than 7.1, Apgar score less than 7 at 5 min, postpartum transfer to neonatal intensive care unit, infection of the newborn

Time frame
from enrollment until final outcome - a month
3

rate of Induction success

the number of participants who had ceasarean section

Time frame
from enrollment until final outcome - a month
4

rate o Cervical ripening success

the duration from the beginning of the induction to bishop score 5

Time frame
from enrollment until final outcome - a month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.